Here we characterize the roles of non-CG methylation in Arabidopsis thaliana. We show that a poorly characterized methyltransferase, CMT2, is a functional methyltransferase in vitro and in vivo. CMT2 preferentially binds histone H3 Lys9 (H3K9) dimethylation and methylates non-CG cytosines that are regulated by H3K9 methylation. We revealed the contributions and redundancies between each non-CG methyltransferase in DNA methylation patterning and in regulating transcription. We also demonstrate extensive dependencies of small-RNA accumulation and H3K9 methylation patterning on non-CG methylation, suggesting self-reinforcing mechanisms between these epigenetic factors. The results suggest that non-CG methylation patterns are critical in shaping the landscapes of histone modification and small noncoding RNA. npg
a r t i c l e s DNA methylation has roles in different biological processes such as gene regulation and imprinting. In Arabidopsis, DNA is methylated in three cytosine contexts: CG, CHG and CHH (where H denotes A, T or C) 1 . In mammals, DNA is primarily methylated in CG contexts; however, studies have uncovered the presence of non-CG methylation in certain cell types such as embryonic stem cells and brain cells [2] [3] [4] [5] [6] [7] . In Arabidopsis, CG methylation is maintained by MET1, the plant homolog of DNMT1. CHG and CHH are site-specifically methylated by CMT3 and DRM2 (refs. 8,9) . CMT3 is controlled by H3K9 methylation [10] [11] [12] . DRM2 is targeted to certain loci through an RNA-directed DNA methylation (RdDM) pathway involving 24-nt small interfering RNAs (siRNAs) 1 . Heterochromatin in Arabidopsis is enriched in both CG and non-CG methylation as well as in H3K9 methylation and 24-nt siRNAs; however, the relationships between each of these marks remain poorly understood.
The abundant non-CG methylation in plants compared to mammals may in part be explained by the presence of plant-specific CMTencoding genes. In addition to CMT3, the Arabidopsis genome contains two other CMT-encoding genes: CMT1 and CMT2. CMT1 is expressed at low levels and is truncated in many Arabidopsis ecotypes 13 . CMT2 is expressed and is a putative DNA methyltransferase. A recent study performed whole-genome methylation profiling in cmt2 mutants and found loss of CHH methylation predominantly at large transposable elements (TEs) that were heterochromatic 9 . Genetic evidence suggested that the chromatin remodeler DDM1 in part allows access for MET1, CMT3 and CMT2 to heterochromatin 9 . However, the mechanism of CMT2 targeting to heterochromatin, its roles and its relationship with other DNA methyltransferases is not understood.
Here, we set out to characterize the roles of non-CG methylation. We first show that CMT2 is a functional non-CG methyltransferase. CMT2 preferentially methylates unmethylated DNA in vitro and methylates both CHG and CHH sites in vitro and in vivo. We find that CMT2 binds methylated H3K9 in vitro and that H3K9 methylation controls non-CG methylation through CMT2. We also uncover that the number of methyl groups on H3K9 may influence targeting of CMT2 and CMT3. Given the identification of CMT2 as a functional methyltransferase, we generated all possible combinations of non-CG methyltransferase mutants and examined the contributions and redundancies between each non-CG methyltransferase in DNA methylation patterning and gene silencing. Although it is clear that 24-nt siRNAs and H3K9 methylation guide non-CG methylation, we reveal extensive dependencies of both 24-nt siRNAs and H3K9 methylation patterning on non-CG methylation. This suggests that non-CG methylation has a critical role in regulating these marks. Furthermore, we find elevated histone acetylation levels throughout sites that lose non-CG methylation. Our results provide insights into targeting of non-CG methylation and will help to guide further studies of the biology of DNA methylation.
RESULTS

CMT2 strongly methylates both CHG and CHH sites in vitro
To examine whether CMT2 has a role in methylating the genome, we performed whole-genome bisulfite sequencing (BS-seq) in two different CMT2 transfer-DNA insertion mutants, cmt2-7 and cmt2-3 (ref. 8) . We found that global CHH methylation was substantially reduced, whereas CG and CHG methylation were largely undisturbed ( Fig. 1a) , results consistent with a recent study 9 . For the rest of the study, we focused on cmt2-7, which we confirmed to be a null mutant by reverse-transcription PCR (Supplementary Fig. 1a) . In contrast to cmt2 mutants, cmt3 mutants lost CHG methylation globally, but CHH methylation was lost only at limited sites in the genome 8 . Thus CMT2 and CMT3 appear to have different sequence preferences.
To understand the difference in sequence specificity between CMT2 and CMT3, we examined CMT2 methyltransferase activity in vitro. To test whether CMT2 could methylate DNA in vitro, we assayed CMT2 activity toward oligonucleotides of different methylation status. We used oligonucleotides that were unmethylated, methylated in all sequence contexts on only one strand (hemimethylated) or, as a negative control, methylated in all sequence contexts on both strands (fully methylated) (Online Methods) 10 . We found that CMT2 preferentially methylated unmethylated oligonucleotides compared to hemimethylated oligonucleotides in vitro (Fig. 1b) . This was in contrast to CMT3, which preferentially methylated hemimethylated oligonucleotides 10 . We further assayed sequence specificity of methylation by CMT2 and found that it did not methylate CG sites (Supplementary Fig. 1c ). Rather, CMT2 strongly methylated both CHG and CHH sites ( Fig. 1c) . This was in contrast to CMT3, which substantially preferred to methylate CHG sites compared to CHH sites 10 (Supplementary Fig. 1b ). Hence the methyltransferase activity of CMT2 is distinct from that of CMT3, such that it preferentially methylates unmethylated DNA and effectively methylates both CHG and CHH sites in vitro. These findings are consistent with our in vivo studies (described below) showing that CMT2 not only mediates CHH methylation but also mediates CHG methylation. CMT2 activity is mediated by H3K9 methylation KRYPTONITE (KYP or SUVH4), SUVH5 and SUVH6 are the major H3K9 methyltransferases in Arabidopsis 11, 12 . We previously showed that loss of CHG methylation in kyp (official symbol suvh4) suvh5 suvh6 triple mutants mimicked the loss of CHG methylation in cmt3 mutants genome wide 8 . However, extensive loss of CHH methylation was also present in kyp suvh5 suvh6 but not in cmt3, thus suggesting that there must be another methyltransferase methylating CHH sites 8 . About 86% of kyp suvh5 suvh6 CHH-hypomethylated sites overlapped with cmt2 CHH-hypomethylated sites, thus suggesting that H3K9 methylation regulates bulk CHH methylation through CMT2 ( Fig. 2a,b) . A smaller fraction of CHH sites regulated by KYP, SUVH5 and SUVH6 overlapped with DRM2-target sites ( Fig. 2a) ; this probably is explained by the dependency of RNA polymerase (Pol) IV recruitment on H3K9 methylation through the histone-binding protein SHH1 (refs. 14,15) . We performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) on dimethylated H3K9 (H3K9me2) in wild-type and kyp suvh5 suvh6 mutants and confirmed that loss of CHH methylation in kyp suvh5 suvh6 was associated with loss of H3K9me2 (Fig. 2b) .
Structural and functional work has suggested that the BAH domain and chromodomain of CMT3 bind methylated H3K9 (ref. 10) . Because CMT2 and CMT3 proteins have very similar domain configurations ( Supplementary Fig. 2a ), we hypothesized that CMT2 may also recognize methylated H3K9. To test this, we assayed binding of recombinant CMT2 protein to different histone modifications on a peptide array. Interestingly, we found preferential binding of CMT2 to H3K9 di-and trimethylated peptides (H3K9me2 and H3K9me3) but less binding to monomethylated H3K9 (H3K9me1) peptides ( Fig. 2c and Supplementary Fig. 2b) , results further confirmed by our isothermal titration calorimetry (ITC) binding data (Fig. 2d) . These data were in contrast to CMT3, which bound H3K9me1, H3K9me2 and H3K9me3 equally well ( Fig. 2e) 10 . In addition, all the ITC binding curves yielded N values around 2, thus indicating that two histone tail peptides bind each CMT molecule and that the dual recognition of methylated H3K9 tails is therefore likely to be a general feature of chromomethylase family of DNA methyltransferases.
The sensitivity of CMT2 to the number of methyl groups on H3K9 in vitro led us to investigate whether this property influences the sites to which CMT2 and CMT3 are targeted. To test this, we performed ChIPseq on H3K9me1 and compared the results to those for H3K9me2. We did not analyze H3K9me3 because this mark is present at extremely low levels 16 and is associated with active genes 17 , which are devoid of non-CG methylation. We compared sites that are regulated by both CMT2 and CMT3 to sites regulated by CMT3 but not CMT2 (Online Methods). At sites regulated by both CMT2 and CMT3, there were higher levels of H3K9me2 compared to those at sites methylated by CMT3 but not CMT2 ( Fig. 2f) . Hence CMT2 is preferentially associated with H3K9me2, whereas CMT3 does not show such preference. This supports our finding that CMT2 binds H3K9me2 with a substantial preference over H3K9me1, whereas CMT3 can bind both H3K9me1 and H3K9me2 almost equally ( Fig. 2c-e ) 10 . Our results indicate that the number of methyl groups on H3K9 may influence CMT protein targeting to the genome. a r t i c l e s npg a r t i c l e s
Interplay between non-CG methyltransferases in methylation
The finding that CMT2 had an important role in maintaining CHH methylation levels in the genome led us to generate mutants containing all possible combinations of non-CG methyltransferase mutants. We crossed cmt2 to cmt3 and to drm1 drm2 double mutants. (DRM1 is expressed only in female gametes 18 .) We generated single-nucleotideresolution maps of DNA methylation in the mutants by performing BS-seq. We first looked at non-CG methylation patterns over all TEs and chromosomes. We found that non-CG methylation in the genome was eliminated in drm1 drm2 cmt2 cmt3 quadruple mutants ( Fig. 3a,b and Supplementary Fig. 3a,b ). This indicated that DRM1, DRM2, CMT2 and CMT3 are collectively responsible for all non-CG methylation in the Arabidopsis genome. This finding enabled us to determine the contributions of each non-CG methyltransferase in DNA methylation patterning. We observed that methylation of both CHG and CHH is redundantly regulated by all non-CG methyltransferases to a certain extent ( Fig. 3a-d) . This suggests that different pathways cooperate to regulate non-CG methylation patterning.
CMT2 and CMT3 methylate CHG sites in a redundant manner
CMT3 tends to methylate large TEs and sites distal to genes 8, 9 . In cmt3 mutants, a strong but partial loss of CHG methylation occurs 8, 9 ( Fig. 3a-d ). We found that in cmt2 cmt3 double mutants there was stronger loss of CHG methylation than in cmt3 mutants ( Fig. 3c ,e-g and Supplementary Fig. 3b ). These sites were nonoverlapping with DRM2-regulated sites (Fig. 3c ). This suggests that although CMT2 preferentially methylates CHH sites, it also methylates CHG sites. This result is consistent with our finding that CMT2 can also methylate CHG sites in vitro (Fig. 1c) . Hence, although the main role of CMT2 is to methylate CHH sites, CMT2 and CMT3 function partially redundantly to methylate CHG sites.
DRM2-target sites are methylated by both DRM2 and CMT3
DRM2 tends to methylate the edges of large TEs as well as small TEs that are proximal to genes 8, 9 . In drm1 drm2 mutants, loss of DNA methylation occurs in CHH contexts and to a lesser extent in CHG contexts 8 (Fig. 3f ). This suggests that a different methyltransferase is methylating CHG at DRM2-target sites. In cmt3 mutants, CHG methylation was partially reduced at DRM2-target sites, and in drm1 drm2 cmt3 triple mutants CHG methylation was nearly completely lost ( Fig. 3f ). Hence CMT3 also methylates DRM2 sites. There was almost complete loss of non-CG methylation at DRM2 sites in drm1 drm2 cmt3 mutants in the presence of a functional CMT2 ( Fig. 3f ). This suggests that CMT2 has a very minor role at DRM2-target sites. Thus, generally at DRM2-target sites, CMT3 and DRM2 methylate cytosines in CHG contexts, and DRM2 methylates cytosines in CHH contexts.
CMT2 and DRM2 mediate all CHH methylation in the genome
Mutations in CMT2 or DRM2 alone are not sufficient to eliminate CHH methylation in the genome ( Fig. 3a-g) . However, we found that drm1 drm2 cmt2 triple mutants essentially eliminated all CHH methylation in the genome (Fig. 3b,d-g) . In fact, 99% of drm1 drm2 cmt2 cmt3 CHH-hypomethylated differentially methylated regions (DMRs) overlapped with drm1 drm2 cmt2 CHH DMRs (Supplementary Fig. 3c ). DRM2 and CMT2 methylate almost completely nonoverlapping sites in the genome (Supplementary Fig. 3d ). Hence a large proportion of heterochromatin can be divided into regions that are CMT2 targeted and those that are DRM2 targeted.
H3K9me1 and H3K9me2 levels at CMT2-and DRM2-target sites
Our finding of CMT2 binding preferentially to H3K9me2 led us to compare H3K9me1 and H3K9me2 levels at target sites of CMT2 a r t i c l e s and DRM2. We found that the relative levels of H3K9me2 to H3K9me1 were higher at CMT2-target sites compared to DRM2target sites (Fig. 3h) . Furthermore, because DRM2 targets the edges of TEs 8, 9 , we sought to examine the distributions of H3K9me1 and H3K9me2 over TEs. We found that H3K9me1 was especially enriched at boundaries of TEs, whereas H3K9me2 was enriched over the bodies of TEs (Fig. 3i) . This distribution of H3K9me1 and H3K9me2 was consistent with the distribution of sites methylated by DRM2 and CMT2 (Fig. 3i) . These results are consistent with the fact that SHH1, a factor involved in recruiting Pol IV to promote DRM2 targeting, exhibits similar in vitro binding to H3K9me1, H3K9me2 and H3K9me3 as that observed for CMT3 ( Fig. 2e) 10, 14, 15 , whereas CMT2 preferably binds H3K9me2 (Fig. 2c,d) . These results further suggest that the number of methyl groups on H3K9 may influence non-CG methyltransferase targeting.
CMT2, CMT3 and DRM2 cooperatively regulate TE expression
DNA methylation is implicated in transcriptional regulation. Because for the first time we possessed a mutant with largely normal levels of CG methylation but a complete lack of non-CG methylation, we were able to test the extent to which non-CG methylation regulates expression of TEs and genes. We performed mRNA sequencing (mRNA-seq) on the different combinations of non-CG methylation mutants (Supplementary Fig. 4a ). We defined TE derepression by using stringent cutoffs (Online Methods) and selected only TEs that showed pronounced misregulation in two biological replicates. TE derepression was most prominent in mutants containing cmt3 mutations, thus suggesting that CMT3 has the strongest role in transcriptional silencing of TEs among non-CG methyltransferases (Fig. 4a) . We found relatively minor upregulation of TEs in cmt2 mutants despite CMT2 methylating a substantial proportion of the genome (Fig. 1a) . This, together with the results that drm1 drm2 or drm1 drm2 cmt2 mutants showed modest TE derepression defects (Fig. 4a) , suggests that CHH methylation itself may not have a major role in TE silencing. However, when combining cmt3 mutations with cmt2 or drm1 drm2 mutations, we observed that an increased number of TEs were upregulated, results suggesting that CHH and CHG methylation redundantly silence TEs (Fig. 4a) . Notably, upon loss of all non-CG methylation in drm1 drm2 npg a r t i c l e s cmt2 cmt3 mutants, there was a large increase in the number of TEs upregulated ( Fig. 4a and Supplementary Fig. 4a ). In fact, there was a global increase in RNA-seq reads in heterochromatic regions in drm1 drm2 cmt2 cmt3 relative to wild type (Fig. 4b) . Although both DNA type and retrotransposons were regulated by non-CG methylation, there was over-representation of DNA Mariner, LINE-1 and longterminal-repeat copia and gypsy transposons ( Supplementary Fig. 4b and Supplementary Table 1 ). Hence different non-CG methyltransferases cooperate to silence TEs in the genome. We next measured the changes in non-CG methylation levels associated with changes in TE expression. The degree of TE upregulation correlated with the degree of loss of non-CG methylation in the mutants, thus indicating that these TEs are indeed regulated by non-CG methylation (Fig. 4c) .
Hence non-CG methylation plays important roles in silencing TEs.
CMT3 and DRM2, but not CMT2, regulate protein-coding genes
DNA methylation also regulates expression of protein-coding genes. By applying the same stringent cutoffs as we did for TEs, we defined 166 protein-coding genes significantly upregulated and 117 genes downregulated in drm1 drm2 cmt2 cmt3 mutants. Genes that became upregulated in drm1 drm2 cmt2 cmt3 mutants were substantially associated with high levels of non-CG methylation in wild type (Supplementary Fig. 4c ) as well as non-CG DMRs in drm1 drm2 cmt2 cmt3 mutants (Fig. 4d ), thus indicating that these genes are regulated by non-CG methylation. In contrast, genes downregulated in drm1 drm2 cmt2 cmt3 mutants did not show association with non-CG methylation, results suggesting that downregulation of these genes is probably an indirect effect ( Fig. 4d and Supplementary Fig. 4c ). This result indicates that non-CG methylation primarily acts as a repressor of transcription. Gene ontology analysis of genes upregulated in drm1 drm2 cmt2 cmt3 mutants indicated some association with response genes (Supplementary Fig. 4d) ; however, the list contained a variety of genes with different functions (Supplementary Table 2 ). DRM2's targeting of sites proximal to genes suggests that it may function to regulate gene expression 8, 9 . These sites are methylated by CMT3 and DRM2 but not CMT2 (Fig. 3f) . Consistently with this, gene upregulation was most prominent in drm1 drm2 cmt3 mutants compared to any other combinations of mutants (Fig. 4e) . In fact, drm1 drm2 cmt2 cmt3 mutants did not show substantial increases in gene expression levels compared to drm1 drm2 cmt3 mutants (Fig. 4e) . This is in contrast to our analysis of TEs (Fig. 4a) . SUPPRESSOR OF drm1 drm2 cmt3 (SDC) is a gene redundantly regulated by DRM2 and CMT3 and is responsible for the developmental phenotypes of drm1 drm2 cmt3 mutants 19 . SDC was not more expressed in drm1 drm2 cmt2 cmt3 compared to drm1 drm2 cmt3 mutants ( Supplementary  Fig. 4e) , results consistent with the morphological defects that the plants exhibited (Supplementary Fig. 4f ). Hence, whereas TEs are cooperatively silenced by DRM2, CMT2 and CMT3, protein-coding genes are largely cooperatively regulated by CMT3 and DRM2 but not CMT2. 
24-nt siRNAs and non-CG methylation at DRM2-target sites
DRM2 is guided by 24-nt siRNAs to target loci 1 . The biogenesis of 24-nt siRNA depends on Pol IV. However, at certain loci siRNA accumulation has also been shown to depend on downstream RdDM factors such as Pol V and DRM2 (refs. 14,20-22) . We sought to examine the extent to which siRNA accumulation depends on non-CG methylation by performing small-RNA sequencing. We found that in drm1 drm2 cmt3 mutants there was strong loss of 24-nt siRNAs (Fig. 5a) . This suggests that loss of non-CG methylation at these sites causes loss of 24-nt siRNAs. Loss of 24-nt siRNAs at these sites was not present in cmt2 mutants, nor was the degree of loss substantially enhanced in drm1 drm2 cmt2 cmt3 mutants compared to drm1 drm2 cmt3 mutants (Fig. 5a) , results consistent with the finding that CMT2 generally does not act at DRM2-target sites. Our results uncover an almost complete dependency of 24-nt siRNA accumulation on non-CG methylation at DRM2-target sites, suggesting a strong self-reinforcing loop mechanism.
24-nt siRNAs and non-CG methylation at CMT2-target sites
Upstream RdDM factors such as Pol IV are responsible for most 24-nt siRNA produced in the genome [23] [24] [25] . By analyzing ChIP-seq data on Pol IV 14 , we confirmed that Pol IV protein was physically enriched at CMT2-target sites (Supplementary Fig. 5a ). Known upstream RdDM mutants such as rdm4, nrpd1a and rdr2, which strongly reduce 24-nt siRNA across the genome [23] [24] [25] [26] , did not substantially reduce CHH methylation at CMT2-dependent sites (Supplementary Fig. 5b) . In contrast, we observed that both drm1 drm2 cmt3 triple mutants and cmt2 single mutants had partial but consistent loss of 24-nt siRNA accumulation at CMT2-target sites (Fig. 5b) . There was substantially more loss of 24-nt siRNAs upon loss of all non-CG methylation in drm1 drm2 cmt2 cmt3 quadruple mutants (Fig. 5b) . This suggests that non-CG methylation partially regulates 24-nt siRNAs at these sites. Although these 24-nt siRNAs do not control non-CG methylation in cis, one possibility is that they target other elements in trans 27 , such as newly inserted TEs 28 . Our results suggest that there is an almost complete dependency of 24-nt siRNA on non-CG methylation at DRM2-target sites and partial dependency of 24-nt siRNA on non-CG methylation at CMT2-target sites. As explored below, a possible mechanism for this dependency may be through H3K9 methylation.
Non-CG methylation globally controls H3K9 methylation
Most non-CG methylation in the genome is regulated by H3K9 methylation (Fig. 2) 8, 10, 14, 15 . H3K9 methylation has also been suggested to be partially dependent on DNA methylation at certain loci, thus suggesting a self-reinforcing loop between DNA methylation and H3K9 methylation [29] [30] [31] . This self-reinforcing loop is probably mediated at least in part by the SRA domains of the H3K9 methyltransferases KYP, SUVH5 and SUVH6, which preferentially bind methylated DNA 29 . However, the extent of this dependency remains poorly understood. We performed ChIP-seq on H3K9me2 in wild type and drm1 drm2 cmt2 cmt3 mutants and the kyp suvh5 suvh6 triple H3K9 methyltransferase mutant. Strikingly, by analyzing the distribution of H3K9me2 across chromosomes, we found strong loss of H3K9me2 in drm1 drm2 cmt2 cmt3 mutants (Fig. 6a) . Inspection of the data on the genome browser confirmed loss of H3K9me2 in drm1 drm2 cmt2 cmt3 mutants ( Fig. 6b and Supplementary Fig. 6a) .
In fact, the degree of loss of H3K9me2 in drm1 drm2 cmt2 cmt3 mutants was as strong as in kyp suvh5 suvh6 mutants (Fig. 6a,b and Supplementary Fig. 6a ). Loss of H3K9me2 in drm1 drm2 cmt2 cmt3 mutants occurred at both CMT2-targeted sites and DRM2-targeted sites, although the loss appeared stronger at CMT2-dependent sites (Fig. 6c) . Strong loss of 24-nt siRNA in drm1 drm2 cmt2 cmt3 mutants at DRM2-target sites (Fig. 5a) is probably partially explained by loss of H3K9 methylation, because 24-nt siRNA accumulation is dependent on the methyl-H3K9-binding protein SHH1 (refs. 14,15) .
Our results indicate that non-CG methylation mediates genome-wide H3K9 methylation patterning.
24-nt siRNA accumulation is mediated by H3K9 methylation
Our finding of extensive self-reinforcing loops between H3K9 methylation and non-CG methylation in part provides an explanation for the self-reinforcing loop between 24-nt siRNA accumulation and non-CG methylation. At DRM2-target sites, non-CG methylation is required for H3K9 methylation (Fig. 6c) , which then regulates 24-nt siRNAs through SHH1 binding to methylated H3K9. Consistently with this model, in kyp suvh5 suvh6 mutants there was a strong loss of 24-nt siRNAs at DRM2-target sites (Fig. 5a) . At CMT2-target sites, non-CG methylation is strongly required for H3K9 methylation (Fig. 6c) .
Consistently with H3K9me2 being lost to a similar extent in drm1 drm2 cmt2 cmt3 and kyp suvh5 suvh6 mutants (Fig. 6a) , we found similar degrees of loss of 24-nt siRNA in drm1 drm2 cmt2 cmt3 and kyp suvh5 suvh6 mutants compared to wild type (Fig. 5b) . Hence it is likely that non-CG methylation controls H3K9 methylation, which then regulates the biogenesis of 24-nt siRNA.
CG methylation and heterochromatic H3K9 methylation
Genome-wide elimination of CG methylation by mutation of the CG methyltransferase MET1 resulted in loss of H3K9me2 at certain sites 32, 33 , although the mechanism is not understood. We analyzed H3K9me2 ChIP data in wild type and met1 mutants 34 . As expected, we observed loss of H3K9me2 at certain sites in met1 mutants (Fig. 6d) . However, we found that these were sites that also lost non-CG methylation in met1 mutants (Supplementary Fig. 6b) . In contrast, we did not observe genome-wide loss of H3K9me2 in met1 mutants, as we found in drm1 drm2 cmt2 cmt3 mutants ( Fig. 6d and Supplementary  Fig. 6c ). This suggests that H3K9 methylation is much more dependent on non-CG methylation than on CG methylation. Although we cannot rule out the possibility that loss of H3K9me2 at certain sites in met1 mutants is directly due to loss of CG methylation, it seems likely that loss of H3K9me2 in met1 mutants is due to loss of non-CG methylation at these sites. Our results suggest that non-CG methylation has a dominant role in regulating H3K9 methylation patterning throughout the genome. Figure 5 Relationship between non-CG methylation and 24-nt siRNA accumulation. (a) 24-nt siRNA levels in DRM2-target sites. 24-nt siRNA levels are normalized by 21-nt siRNA levels for each genotype. One replicate per genotype was analyzed. (b) 24-nt siRNA levels in CMT2-target sites. npg a r t i c l e s
Loss of non-CG methylation induces histone hyperacetylation
Histone acetylation is associated with open chromatin and actively transcribed genes. Given the strong loss of the repressive histone mark H3K9me2 in drm1 drm2 cmt2 cmt3, we sought to examine the effects on genome-wide histone acetylation patterns. We performed ChIP-seq on acetylated histone H3 K23 (H3K23ac) and histone H3 on wild type and drm1 drm2 cmt2 cmt3 and kyp suvh5 suvh6 mutants. As expected, H3K23ac was enriched in promoter regions of active genes in wild type (Supplementary Fig. 6d) . We observed genome-wide increases of histone acetylation in drm1 drm2 cmt2 cmt3 mutants and kyp suvh5 suvh6 mutants at sites that lost DNA methylation (Fig. 6c,e and Supplementary Fig. 6e ). Elevation of histone acetylation levels was not restricted to transcriptionally upregulated TEs and genes ( Fig. 6e and Supplementary Fig. 6f) , thus suggesting that this phenomenon cannot simply be explained by more transcription in the mutants. Consistently with the elevation in histone acetylation, we found substantial chromocenter decondensation in drm1 drm2 cmt2 cmt3 mutants (Supplementary Fig. 6g ). Hence non-CG methylation is required to keep heterochromatin in a deacetylated and compacted state.
DISCUSSION
In this study, we characterized a series of mutants affecting non-CG methylation, including the poorly understood methyltransferase CMT2. This analysis has uncovered the roles of each non-CG methyltransferase in DNA methylation patterning and gene silencing. Furthermore, our finding of extensive cross-talk between non-CG methylation and H3K9 methylation provides insights into the mechanisms of cross-talk between different silencing pathways. All data generated in this study can be visualized in a modified UCSC browser (http://genomes.mcdb.ucla. edu/AthBSseq/) along with other epigenomic data sets. At DRM2-target sites, there is a selfreinforcing loop between non-CG methylation, H3K9 methylation and 24-nt siRNAs (Fig. 7a) . H3K9 methylation is required for CMT3 targeting to methylate CHG sites at a subset of DRM2 sites as well as for DRM2 targeting through binding of SHH1 (ref. 14) , which methylates the remaining non-CG sites. SHH1 binding to methylated H3K9 is required for 24-nt siRNA accumulation at a subset of DRM2 sites 14 . The 24-nt siRNAs then direct DRM2 (ref. 35) . Our data suggest that non-CG methylation is required for H3K9 methylation, which is largely mediated by KYP, SUVH5 and SUVH6. The H3K9 methylation then directs CMT3 and DRM2 pathways for non-CG methylation.
At CMT2-target sites, there is also a self-reinforcing loop between non-CG methylation, H3K9 methylation and 24-nt siRNAs (Fig. 7b) . Our results suggest that both CMT2 and CMT3 mediate CHG methylation, and CMT2 mediates CHH methylation at these sites through binding to methylated H3K9. Non-CG methylation mediated by CMT2 and CMT3 regulates H3K9 methylation mediated by KYP, SUVH5 and SUVH6. H3K9 methylation may then partially regulate 24-nt siRNAs produced at these sites through a similar mechanism of recruitment of H3K9 methylation readers that occurs at DRM2-target sites: Because these 24-nt siRNAs are also dependent on Pol IV 25, 26 , there may be H3K9
Chr1 Chr4
Wild type drm1 drm2 cmt2 cmt3 kyp suvh5 suvh6 H3K9me2 is normalized to histone H3. Two wild-type H3K9me2 data sets are shown because H3K9me2 data for met1 have a separate wild-type control 34 . (e) Genome-browser views of DNA methylation, expression levels, H3K23ac and H3K9me2 in wild type and drm1 drm2 cmt2 cmt3 and kyp suvh5 suvh6 mutants in chromosome 1. Yellow bars, genes. npg a r t i c l e s methylation readers other than SHH1 that recruit Pol IV to CMT2 sites. Although these 24-nt siRNAs do not appear to have a major role in guiding DRM2 in cis, they might function to silence TEs in trans 27, 28 .
In summary, our data demonstrate that the CMT2, CMT3 and DRM2 methyltransferases collaborate to control non-CG methylation and participate in self-reinforcing loop mechanisms with H3K9 methylation and small RNAs to control gene silencing throughout the genome.
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